These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3010363)

  • 21. The effects of yohimbine on exploratory and locomotor behaviour are attributable to its effects at noradrenaline and not at benzodiazepine receptors.
    Chopin P; Pellow S; File SE
    Neuropharmacology; 1986 Jan; 25(1):53-7. PubMed ID: 2869438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic benzodiazepine administration. X. Concurrent administration of the peripheral-type benzodiazepine ligand PK11195 attenuates chronic effects of lorazepam.
    Miller LG; Galpern WR; Byrnes JJ; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1992 Apr; 261(1):285-9. PubMed ID: 1313872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lorazepam and pentobarbital drug discrimination in baboons: cross-drug generalization and interaction with Ro 15-1788.
    Ator NA; Griffiths RR
    J Pharmacol Exp Ther; 1983 Sep; 226(3):776-82. PubMed ID: 6136600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial effect of pharmacological modulation of the GABAA-benzodiazepine receptor on hepatic encephalopathy in the rat: comparison with uremic encephalopathy.
    Steindl P; Püspök A; Druml W; Ferenci P
    Hepatology; 1991 Dec; 14(6):963-8. PubMed ID: 1660024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of benzodiazepine receptor inverse agonists on locomotor activity and exploration in mice.
    Jackson HC; Nutt DJ
    Eur J Pharmacol; 1992 Oct; 221(2-3):199-203. PubMed ID: 1330620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral interactions between ethanol and imidazodiazepines with high affinities for benzodiazepine receptors.
    Lister RG
    Life Sci; 1988; 42(14):1385-93. PubMed ID: 2832675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of chronic treatment with peripheral benzodiazepine receptor ligands on behavior and GABAA/benzodiazepine receptors in rat.
    Rägo L; Saano V; Auvinen T; Adojaan A; Holma R; Airaksinen MM
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):432-6. PubMed ID: 1331816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using Ro 15-1788 to investigate the benzodiazepine receptor in vivo: studies on the anticonvulsant and sedative effect of melatonin and the convulsant effect of the benzodiazepine Ro 05-3663.
    Green AR; Nutt DJ; Cowen PJ
    Psychopharmacology (Berl); 1982; 78(3):293-5. PubMed ID: 6296905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are the anxiogenic effects of yohimbine mediated by its action at benzodiazepine receptors?
    Pellow S; Chopin P; File SE
    Neurosci Lett; 1985 Mar; 55(1):5-9. PubMed ID: 2986061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the benzodiazepine antagonist Ro 15-1788 reverse the actions of picrotoxin and pentylenetetrazole on social and exploratory behaviour?
    File SE; Pellow S
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):272-9. PubMed ID: 2865937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of chlordiazepoxide training dose on the mixed agonist-antagonist properties of benzodiazepine receptor antagonist Ro 15-1788, in a drug discrimination procedure.
    De Vry J; Slangen JL
    Psychopharmacology (Berl); 1986; 88(2):177-83. PubMed ID: 3006110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nonuniform effect of prolonged haloperidol administration on the GABA(A) and benzodiazepine receptors in different parts of the brain].
    Vasar EE; Nurk AM; Maĭmets MO; Soosaar AKh; Allikmets LKh
    Biull Eksp Biol Med; 1986 Apr; 101(4):433-6. PubMed ID: 3008878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A behavioral examination of convulsant benzodiazepine and GABA antagonist, Ro 5-3663, and benzodiazepine-receptor antagonist Ro 15-1788.
    Feldon J; Lerner T; Levin D; Myslobodsky M
    Pharmacol Biochem Behav; 1983 Jul; 19(1):39-41. PubMed ID: 6413985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cleft palate and open eyelids inducing activity of lorazepam and the effect of flumazenil, the benzodiazepine antagonist.
    Jurand A; Martin LV
    Pharmacol Toxicol; 1994; 74(4-5):228-35. PubMed ID: 8090691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic treatment with lorazepam and FG 7142 may change the effects of benzodiazepine receptor agonists, antagonists and inverse agonists by different mechanisms.
    Petersen EN; Jensen LH
    Eur J Pharmacol; 1987 Jan; 133(3):309-17. PubMed ID: 3030777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precipitated and spontaneous withdrawal following administration of lorazepam but not zolpidem.
    Elliot EE; White JM
    Pharmacol Biochem Behav; 2000 Jun; 66(2):361-9. PubMed ID: 10880691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progesterone withdrawal increases the alpha4 subunit of the GABA(A) receptor in male rats in association with anxiety and altered pharmacology - a comparison with female rats.
    Gulinello M; Gong QH; Smith SS
    Neuropharmacology; 2002 Sep; 43(4):701-14. PubMed ID: 12367616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RO5-4864, a ligand for benzodiazepine micromolar and peripheral binding sites: antagonism and enhancement of behavioural effects.
    File SE; Pellow S
    Psychopharmacology (Berl); 1983; 80(2):166-70. PubMed ID: 6308704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzodiazepine receptors mediate regional blood flow changes in the living human brain.
    Matthew E; Andreason P; Pettigrew K; Carson RE; Herscovitch P; Cohen R; King C; Johanson CE; Greenblatt DJ; Paul SM
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2775-9. PubMed ID: 7708722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal.
    Griffiths RR; Evans SM; Guarino JJ; Roache JD; Furman WR; Liebson I; Schwam EM
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1163-74. PubMed ID: 8510001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.